GlassScriptPhysician profile
Omar Soliman
NPI 1538923180
$895.24
in general payments reported to CMS, 2019-2025
14 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $481 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.01 | 2024-2025 | Relistor |
| Valinor Pharma, LLC | $178.95 | 2024-2025 | Movantik |
| Collegium Pharmaceutical, INC. | $121.44 | 2024-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $87.24 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $56.00 | 2024-2025 | |
| Impel Pharmaceuticals LLC | $41.12 | 2025 | Trudhesa |
| Pfizer INC. | $38.27 | 2025 | |
| Vertos Medical, INC. | $37.68 | 2024 | Mild Device Kit |
| Ossur Americas, INC. | $30.89 | 2025 | Unloader One X |
| Nevro Corp. | $24.09 | 2024 | Senza |
| Spr Therapeutics, INC | $18.38 | 2024 | Sprint Pns System |
| Astrazeneca Pharmaceuticals LP | $17.19 | 2025 | Wainua |
| Abbott Laboratories | $15.99 | 2024 | Proclaim |
| Appliedvr INC | $15.99 | 2025 | Relievrx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Soliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.